GLAND PHARMA
Back to Balance Sheet
|
GLAND PHARMA Last 5 Year Capital Work in Progress History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Capital Work in Progress | ₹151 Cr | ₹238 Cr | ₹177 Cr | ₹181 Cr | ₹338 Cr |
What is the latest Capital Work in Progress ratio of GLAND PHARMA ?
| Year | Capital Work in Progress |
|---|---|
| Mar2025 | ₹151 Cr |
| Mar2024 | ₹238 Cr |
| Mar2023 | ₹177 Cr |
| Mar2022 | ₹181 Cr |
| Mar2021 | ₹338 Cr |
How is Capital Work in Progress of GLAND PHARMA Trending?
| Years | Capital Work in Progress | % Change | |
|---|---|---|---|
| Mar2025 | ₹151 Cr | -36.71 | |
| Mar2024 | ₹238 Cr | 34.23 | |
| Mar2023 | ₹177 Cr | -1.95 | |
| Mar2022 | ₹181 Cr | -46.49 | |
| Mar2021 | ₹338 Cr | - | |
Compare Capital Work in Progress of peers of GLAND PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GLAND PHARMA | ₹30,521.8 Cr | -2.4% | 8.4% | 21% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹406,615.0 Cr | 4% | -4.9% | -2.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹159,943.0 Cr | 1.1% | -9.3% | 9.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹133,336.0 Cr | -1.3% | -3.7% | 24% | Stock Analytics | |
| CIPLA | ₹107,499.0 Cr | 1.5% | -9.3% | -7.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,590.0 Cr | 5% | -0.1% | 3.3% | Stock Analytics | |
GLAND PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GLAND PHARMA | -2.4% |
8.4% |
21% |
| SENSEX | 3.5% |
-1.7% |
7.8% |
You may also like the below Video Courses